CYIG's Research Advances Through the Cooperation With NFU

CYIG's Research Advances Through the Cooperation With NFU

SHANDONG, China, July 22, 2014 (GLOBE NEWSWIRE) -- China YCT International
Group, Inc (OTC:CYIG) has recently held a work conference with Nanjing
Forestry University (NFU). The two sides had in-depth communications about the
company development and the future of acer truncatum as well as the
cooperation plan.

Cao Fu Liang, Principal of the NFU stated at the conference that after several
years cooperation with CYIG, both have achieved a lot of scientific goals in
gingko research and production. During this time, CYIG took on some
governmental programs including the national Torch Program, the Provincial and
National Enriching People and County programs and were awarded a second place
in the China national scientific progress prize.

As a high-tech enterprise, the Company built a technologically innovative
platform consisting of provincial engineering technology research center and
the preparation engineering laboratory. The researchers in the Center consist
of more than 20 professionals and many other engineers of which 60% of them
are senior level. The Center is equipped with provincial standardized
experimental facilities and is thus suited to national and provincial research
plans and tests, and sets down products techniques and processes for the
Company. The Center holds 4 national invention patents.

The Laboratory contains 2 workshops. The natural medicine extraction shop is
responsible for extracting, isolating and purifying the functional ingredients
from the gingko aglycone flavonoids and acer truncatum at the same time. The
shop can also deal with a hundred more Chinese medical herbs extraction and
purification.

Based on downstream products of gingko and acer truncatum, the biological feed
shop adopted biological fermentation and enzyme technology to produce
antibiotic-free additives which could replace the antibiotic additives has now
being widely used in cultivation industry.

Mr. Tinghe Yan,The CEO of CYIG commented that, "CYIG has grown up as time goes
by and now became a famous China pharmaceutical company with rapid growth.
Adhere to the enterprise purpose of 'casting quality and building the brand in
the future, CYIG is stepping onto the worldwide stage and embracing the new
period of fast development."

With the development of our society and the evolvement of the human being,
health has became the most concerned thing. CYIG views the public healthcare
as its duty and therefore helps people by their various kind of medicine
products to make a better society and world.

The Strategy leads the development and innovation drives the progress. Under
the Five Years Development Plan of CYIG, the company implements the strategy
for the project to rapidly expand the business scale and market share. We will
carry forward the company's advanced culture, strive to explore a new business
model, commit to the enterprise long-term value creation, and provide
consumers good quality and efficient products and services. Meanwhile, we will
actively fulfill the social responsibility, return our shareholders,
customers, society and employees with fruitful results from the development of
enterprise, realize the aim of 'the pursuit of profits'".

For more information, visit www.yctgroup.com

Safe Harbor Statement

Certain statements in this press release, constitute forward-looking
statements for purposes of the safe harbor provisions under The Private
Securities Litigation Reform Act of 1995. These statements include, without
limitation, statements regarding the Company's future performance. The Company
has based these forward-looking statements largely on its current expectations
and projections about future events and financial trends that we believe may
affect our financial condition, results of operations, business strategy and
financial needs. Although the Company believes that the expectations reflected
in these forward-looking statements are reasonable, they do involve
assumptions, risks and uncertainties, and these expectations may prove to be
incorrect. Investors should not place undue reliance on these forward-looking
statements, which speak only as of the date of this press release. The
Company's actual results could differ materially from those anticipated in
these forward-looking statements as a result of a variety of factors,
including those discussed in the periodic reports that are filed with the
Securities and Exchange Commission. All forward-looking statements
attributable to the Company or persons acting on its behalf are expressly
qualified in their entirety by these factors. The Company undertakes no duty
to update these forward-looking statements except as required by law.

CONTACT: Zecheng Shao
         Tel: 0086-537-4268276
         Email: zecheng.shao@gmail.com
 
Press spacebar to pause and continue. Press esc to stop.